About Event

Final Discount Expires Friday!

Day
Hour
Minute
Second

Welcome to Your CAR-TCR One Stop Shop

The world’s pre-eminent industry-leading comprehensive forum, the 7th CAR-TCR Summit, is back in Boston with a bang! Join the global community as we explore discovery through to commercialization to deliver safe, effective and commercially viable CAR and TCR therapies.

Across 3 main conference days and 8 tracks, 200+ CAR and TCR experts will lead you and your peers in discussions from novel allogeneic approaches with enhanced safety considerations, the latest in vivo gene engineering techniques, and advances in CMC strategies and analytical development to ensure development of high-quality cell products.

With your industry reuniting in-person for the first time since 2019 to discuss leveraging the powerful potential of iPSC platforms, learnings from our successes and pitfalls, and manufacturing automation innovations for large scale consistent production, you can’t afford to miss the 7th CAR-TCR Summit as we bring you more speakers, more content and more exclusive insights than ever before!

5 Reasons this is a Must-Attend:

Discover the latest in vivo gene engineering techniques to improve safety, tolerability and efficacy for complex cell therapies with Capstan Therapeutics, Mustang Bio, ImmTune Therapies and Umoja Biopharma

Uncover the blockbuster potential of combining modalities by leveraging the power of CAR technology across T-cells, NK cells, iPSC and macrophages with Notch Therapeutics, Carisma Therapeutics,Catamaran Bio, Fate Therapeutics and more

Elevate your CMC and analytical workstreams with Vor Biopharma, Triumvira Immunologics, Kyverna Therapeutics and Adicet Bio to optimize development of safe and high-quality cell products

Achieve success during early phase 1/2 development as seasoned industry experts from the likes of T-Knife Therapeutics, Bristol Myers Squibb, IN8bio and Immatics showcase how to seamlessly scale up and build phase appropriate infrastructure

Expedite development of commercially viable therapies with Gilead, Chimeric Therapeutics,
Autolus and Takeda as they explore novel pricing and reimbursement models and explore
how to prepare for commercial readiness right from product conception

Event in Numbers

1000+

Attendees

15

Workshops

300+

Companies

8

Tracks

200+

Speakers

4

Days of Content

140+

Hours of Content

3

Main Conference Days

The CAR-TCR Series

The CAR-TCR Event Series is committed to delivering an exclusive platform to unite the community and explore the key challenges to your industry, guided by global thought leaders in each discipline.

Dedicated to the development of safe, clinically effective and globally accessible therapies, the series is an unrivalled opportunity to gather with experts in your discipline.

From next-generation development to supply chain and logistics, and exploring challenges specific to each area, we create these forums to deliver value and in-depth learnings across the development pipeline, on a global stage.

Other Events in the Series:

Connect With Us

Join Our Twitter Following:

Join the LinkedIn Community: